XML 20 R9.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities:    
Net income $ 18,689 $ 13,478
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision (credit) for credit losses (836) (535)
Depreciation, amortization, accretion 1,862 1,881
Deferred taxes 493 325
Stock based compensation 336 211
Origination of mortgage servicing rights (480) (640)
Gain on sale of loans held for sale (60,288) (66,824)
Loans originated for sale (1,512,282) (1,662,426)
Proceeds on sales of loans originated for sale 1,572,803 1,738,397
Increase in accrued interest receivable (253) (343)
Increase in cash surrender value of life insurance (2,021) (1,562)
Decrease in derivative assets 5,113 1,974
Increase in accrued interest on deposits and borrowings 475 4,709
Increase in accrued taxes 1,368 303
Gain on sale of mortgage servicing rights 0 (152)
Decrease in derivative liabilities (4,801) (2,916)
Decrease (increase) in other assets 906 (1,430)
(Decrease) increase in other liabilities (74) 183
Net cash provided by operating activities 21,010 24,633
Investing activities:    
Net increase in loans receivable (34,188) (31,100)
Debt securities (9,182) (12,201)
Mortgage related securities (28,587) (10,774)
Bank Owned Life Insurance (180) (180)
FHLB stock (2,463) (2,340)
Premises and equipment (619) (745)
Principal repayments on mortgage-related securities 18,567 16,695
Maturities of debt securities 9,000 5,728
Sales of FHLB Stock 2,051 1,539
Sales of mortgage servicing rights 0 2,110
Net cash used in investing activities (45,601) (31,268)
Financing activities:    
Net increase in deposits 26,076 73,217
Net change in short-term borrowings (37,458) (55,927)
Repayment of long-term debt (70,000) (145,000)
Proceeds from long-term debt 130,000 150,000
Net change in advance payments by borrowers for taxes 9,329 9,318
Cash dividends on common stock (8,130) (8,507)
Purchase of common stock returned to authorized but unissued (13,485) (12,115)
Proceeds from stock option exercises 2,266 635
Net cash provided by financing activities 38,598 11,621
Increase in cash and cash equivalents 14,007 4,986
Cash and cash equivalents at beginning of period 39,761 36,421
Cash and cash equivalents at end of period 53,768 41,407
Supplemental information:    
Income tax payments 2,843 3,173
Interest payments 45,448 55,492
Noncash activities:    
Dividends declared but not paid in other liabilities $ 2,880 $ 2,993